Literature DB >> 2004274

Detection of unusual RNA folding regions in HIV and SIV sequences.

S Y Le1, J H Chen, J V Maizel.   

Abstract

We have developed a method for detecting more stable and significant folding regions relative to others in the sequence. The algorithm is based on the calculation of the lowest free energy of RNA secondary structures and Monte Carlo simulation. For any given RNA segment, the stability and statistical significance of RNA folding are assessed by two measures: the stability score and the significance score. The stability score measures the degree of thermodynamic stability of the segment between all possible biological segments in the RNA sequence. The significance score characterizes the specific arrangement of the nucleotides in the segment that could imply a structural role for the sequence information. Using these two measures, we are able to detect a series of distinct folding regions where highly stable and statistically significant secondary structures occur in human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) sequences.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004274     DOI: 10.1093/bioinformatics/7.1.51

Source DB:  PubMed          Journal:  Comput Appl Biosci        ISSN: 0266-7061


  3 in total

1.  Antiviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase occur in specific RNA structural regions.

Authors:  R F Schinazi; R M Lloyd; C S Ramanathan; E W Taylor
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

2.  Reciprocal relationship between stem-loop potential and substitution density in retroviral quasispecies under positive Darwinian selection.

Authors:  D R Forsdyke
Journal:  J Mol Evol       Date:  1995-12       Impact factor: 2.395

3.  Hidden messages in the nef gene of human immunodeficiency virus type 1 suggest a novel RNA secondary structure.

Authors:  Ofer Peleg; Edward N Trifonov; Alexander Bolshoy
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.